Integrated  	Integrated  	 NNP	B-NP
community  	community  	 NN	I-NP
case  	case  	 NN	I-NP
management  	management  	 NN	I-NP
of  	of  	 IN	O
fever  	fever  	 NN	O
in  	in  	 IN	O
children  	children  	 NNS	O
under  	under  	 IN	O
five  	five  	 CD	O
using  	using  	 VBG	O
rapid  	rapid  	 JJ	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
tests  	tests  	 NNS	I-NP
and  	and  	 CC	O
respiratory  	respiratory  	 JJ	B-NP
rate  	rate  	 NN	I-NP
counting 	counting 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
multi-country  	multi-country  	 JJ	B-NP
cluster  	cluster  	 NN	I-NP
randomized  	randomized  	 NN	O
trial  	trial  	 NN	B-NP
Evidence  	Evidence  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
impact  	impact  	 NN	O
of  	of  	 IN	O
using  	using  	 VBG	O
diagnostic  	diagnostic  	 JJ	B-NP
tests  	tests  	 NNS	I-NP
in  	in  	 IN	O
community  	community  	 NN	B-NP
case  	case  	 NN	I-NP
management  	management  	 NN	I-NP
of  	of  	 IN	O
febrile  	febrile  	 JJ	O
children  	children  	 NNS	O
is  	is  	 VBZ	O
limited 	limited 	 VBN	O
.  	.  	 .	O
This  	This  	 DT	O
effectiveness  	effectiveness  	 NN	B-NP
trial  	trial  	 NN	I-NP
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
Burkina  	Burkina  	 NNP	O
Faso 	Faso 	 NNP	O
,  	,  	 ,	O
Ghana 	Ghana 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Uganda 	Uganda 	 NNP	B-NP
,  	,  	 ,	O
compared  	compared  	 VBN	O
a  	a  	 DT	O
diagnostic  	diagnostic  	 JJ	B-NP
and  	and  	 CC	O
treatment  	treatment  	 NN	B-NP
package  	package  	 NN	I-NP
for  	for  	 IN	O
malaria  	malaria  	 NN	O
and  	and  	 CC	O
pneumonia  	pneumonia  	 NN	O
with  	with  	 IN	O
presumptive  	presumptive  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
anti-malarial  	anti-malarial  	 JJ	B-NP
drugs 	drugs 	 NNS	I-NP
;  	;  	 :	O
artemisinin  	artemisinin  	 JJ	B-NP
combination  	combination  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
( 	( 	 -LRB-	O
ACT 	ACT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
enrolled  	enrolled  	 VBD	O
4,216  	4,216  	 CD	O
febrile  	febrile  	 CD	O
children  	children  	 NNS	O
between  	between  	 IN	O
4  	4  	 CD	O
and  	and  	 CC	O
59  	59  	 CD	O
months  	months  	 NNS	O
of  	of  	 IN	O
age  	age  	 NN	O
in  	in  	 IN	O
2009-2010 	2009-2010 	 CD	O
.  	.  	 .	O
Compliance  	Compliance  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
malaria  	malaria  	 JJ	O
rapid  	rapid  	 JJ	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
test  	test  	 NN	I-NP
( 	( 	 -LRB-	O
RDT 	RDT 	 NNP	B-NP
)  	)  	 -RRB-	O
results  	results  	 NNS	O
was  	was  	 VBD	O
high  	high  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
intervention  	intervention  	 NN	B-NP
arm  	arm  	 NN	I-NP
across  	across  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
countries 	countries 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
only  	only  	 RB	O
4.9 	4.9 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
17  	17  	 CD	O
of  	of  	 IN	O
344 	344 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
RDT-negative  	RDT-negative  	 JJ	B-NP
children  	children  	 NNS	I-NP
prescribed  	prescribed  	 VBN	O
an  	an  	 DT	O
ACT 	ACT 	 NNP	O
.  	.  	 .	O
Antibiotic  	Antibiotic  	 JJ	B-NP
overuse  	overuse  	 NN	I-NP
was  	was  	 VBD	O
more  	more  	 RBR	O
common 	common 	 JJ	O
:  	:  	 :	O
0.9 	0.9 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
4  	4  	 CD	O
of  	of  	 IN	O
446 	446 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
Uganda 	Uganda 	 NNP	B-NP
,  	,  	 ,	O
38.5 	38.5 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
114  	114  	 CD	O
of  	of  	 IN	O
296 	296 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
Burkina  	Burkina  	 NNP	O
Faso 	Faso 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
44.6 	44.6 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
197  	197  	 CD	O
of  	of  	 IN	O
442 	442 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
Ghana 	Ghana 	 NNP	B-NP
.  	.  	 .	O
Fever  	Fever  	 NN	B-NP
clearance  	clearance  	 NN	I-NP
was  	was  	 VBD	O
high  	high  	 JJ	O
in  	in  	 IN	O
both  	both  	 DT	O
intervention  	intervention  	 NN	B-NP
and  	and  	 CC	O
control  	control  	 NN	B-NP
arms  	arms  	 NNS	I-NP
at  	at  	 IN	O
both  	both  	 DT	O
Day  	Day  	 NNP	O
3  	3  	 CD	O
( 	( 	 -LRB-	O
97.8 	97.8 	 CD	O
%  	%  	 NN	O
versus  	versus  	 IN	O
96.9 	96.9 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.17 	0.17 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Day  	Day  	 NNP	O
7  	7  	 CD	O
( 	( 	 -LRB-	O
99.2 	99.2 	 NNP	O
%  	%  	 NN	O
versus  	versus  	 IN	O
98.8 	98.8 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.17 	0.17 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
tests  	tests  	 NNS	I-NP
limits  	limits  	 VBZ	O
overuse  	overuse  	 VBN	O
of  	of  	 IN	O
ACTs 	ACTs 	 JJ	O
.  	.  	 .	O
Its  	Its  	 PRP$	O
impact  	impact  	 NN	O
on  	on  	 IN	O
antibiotic  	antibiotic  	 JJ	B-NP
overuse  	overuse  	 NN	I-NP
and  	and  	 CC	O
on  	on  	 IN	O
fever  	fever  	 NN	B-NP
clearance  	clearance  	 NN	I-NP
is  	is  	 VBZ	O
uncertain 	uncertain 	 JJ	O
.  	.  	 .	O
